'The role of the court in making an assessment of damages which depends upon its view as to what will be and what would have been is to be contrasted with its ordinary function in civil actions of determining what was. In determining what did happen in the past a court decides on the balance of probabilities. Anything that is more probable than not it treats as certain. But in assessing damages which depend upon its view as to what will happen in the future or would have happened in the future if something had not happened in the past, the court must make an estimate as to what are the chances that a particular thing will or would have happened and reflect those chances, whether they are more or less than even, in the amount of damages it awards.'
'To decide otherwise would be a blanket release from liability for doctors and hospitals any time there was less than a 50 per cent chance of survival, regardless of how flagrant the negligence.'
"The rule against recovery of uncertain damages is directed against uncertainty as to cause rather than as to extent or measure."
"In the present case, the evidence clearly established that the cancer had spread, on the findings of the judge, by reason of the negligence of the respondent. That was all that was necessary to found his claim in negligence. Once that had been established, the question for the court was the extent to which the consequences, which included the reduced prospects of successful treatment, could themselves be established as an issue of quantification of damage."
"To be acceptable the law must be coherent. It must be principled. The basis on which one case, or one type of case, is distinguished from another should be transparent and capable of identification. When a decision departs from principles normally applied, the basis for doing so must be rational and justifiable if the decision is to avoid the reproach that hard cases make bad law."
"It was the enlargement of the tumour which reduced the chances of successfully treating it. This aspect of the plaintiff's claim was never addressed by the judge. Nonetheless the judge's findings amply support the submission that the appellant had indeed suffered injury which entitled the appellant to general damages for the pain and suffering which were the physical consequence of the spread of the tumour, an assessment of the extent to which delay resulted in more intensive therefore damaging treatment, an assessment of the increased risk of relapse and the adverse effect on prognosis, involving an assessment of the consequences to the appellant's expectation of life."
"I have selected references to the views expressed by the judges who took part in this decision to illustrate the variety of views open in this difficult area of the law. These confirm me in the view that it would not be right in the present case to affirm the general proposition for which Mr Whitfield contended [that damages could not be awarded for loss of a chance: see p 783]. On the other hand, none of the views canvassed in Herskovits' case, 664 P2d 474, would lead to the plaintiff succeeding in the present case since the judge's findings in fact mean that the sole cause of the plaintiff's avascular necrosis was the injury he sustained in the original fall, and that implies, as I have said, that when he arrived at the authority's hospital for the first time he had no chance of avoiding it. Accordingly, the subsequent negligence of the authority did not cause him the loss of such a chance."
"Of those with initial treatment by CHOP chemotherapy with or without field radiotherapy 55 will achieve complete remission. 45 will not achieve complete remission, and of those 41 will then die. Four who did not achieve complete remission immediately will be brought to achieve it by further treatment of various kinds. Thus of the initial 100 59 manage to achieve complete remission. Of those 35 do not relapse. They are described by Professor Goldstone as the core group of survivors. 24, however, do relapse (usually, if they are going to, within two years or so of achieving remission). Of those 24 half, a further 12, will not be responsive to further treatment and will die. The remaining 12 will be responsive to further treatment, typically high dose chemotherapy with stem cell harvesting such as the claimant himself went through. Of those 12 half, a further six, will not relapse again and will become survivors. Of the remaining six who do relapse again, only one will survive. The number of survivors from the 100 who started out will therefore be 42. Mr Gregg's disease and treatment has not quite taken this course, since he is probably to be regarded as someone who attained complete remission only after stem cell treatment and high dose chemotherapy. But he is someone who, having received that treatment, subsequently relapsed. He may therefore be regarded as possibly the one survivor [at] the end of the process described in the model. He had after his relapse in early 1998 a 10% or 15% chance of survival. However, he has now survived over three years, and as time goes by the chances of relapse diminish. The best that Professor Goldstone can say of it now, however, is that given all that has happened, at present Mr Gregg's chances of survival for five years is less than 50%, though he put a figure of 20% to 30% as the present chance as best as he could assess it."
"The 100 patients in the worked example include all ages, and also people with other unrevealed personal characteristics, one of which is the stage of the disease at diagnosis"
"There is no doubt that in the present case, the delay in diagnosis caused the tumour to enlarge, invade neighbouring tissue and cause severe pain. It was the enlargement of the tumour which reduced the chances of successfully treating it. This aspect of the plaintiff's claim was never addressed by the judge. Nonetheless, the judge's findings amply support the submission that the appellant had indeed suffered injury which entitled the appellant to general damages for the pain and suffering which were the physical consequence of the spread of the tumour, an assessment of the extent to which delay resulted in more intensive therefore damaging treatment, an assessment of the increased risk of relapse and the adverse effect on prognosis, involving an assessment of the consequences to the appellant's expectation of life."
"The head of loss in respect of which the claimant is seeking to claim is diminution of his life expectancy. That represents a substantive head of claim, for which the claimant could recover if he could show, as a matter of probability, that the respondents' negligence had caused it. If damages cannot be recovered for that as such, it is because the appellant cannot show (as I have concluded that he would have to) that he was not already going to suffer that head of loss, independently of the negligence. It is not possible to change the starting point to the enlarged tumour and to ask the court to assess the prospects that this made any difference to the claimant's life expectancy."
"the most obvious influencing factors are, one would suppose, internal to the claimant at the time of the negligence, however unknown or unknowable they may be; and they consist of the precise characteristics, development and spread of the cancerous cells at the time of the negligence as well as the claimant's precise physical characteristics and resistance. Other influencing factors may very well include subsequent events such as the particular medical treatment received, the patient's subsequent life-style and his or her, or indeed others', reaction to the stress inevitably incurred."
"The evidence was that 59 of the original 100 would have survived initial treatment and that the appellant was, necessarily, one of those. Of those 59, 17 went on to die. That amounts to (say) 28%. Thus, assessed at the date of trial the appellant would have had a 72% chance of survival had he received appropriate treatment. On the expert evidence that chance was reduced by the negligent delay: it had been 10%-15% assessed at the date treatment should have been given but had increased to 20%-30% as at the date of trial (paragraph 34, last sentence). Thus, if (as the judge did) one takes the mid-way point the appellant's lost chance assessed at the date of trial was 72% - 25% = 47%. In those circumstances the correct approach was to have awarded the appellant damages on the basis of a 47% loss of the chance of survival."
"As to the effect of delay on the course of treatment, if he does not survive he would have gone through the various stages anyway. The probability is that he will not survive. If he does, it is more likely than not that he would have been cured by simple treatment, CHOP only, or less therapy, but that is using the overall data and not the ALK data."
"It is possible to say on the basis of Professor Goldstone's model that he would more probably than not have achieved complete remission with initial CHOP therapy and without high dose chemotherapy with stem cell harvesting."
"In this case the claimant has failed to prove that it is more probable than not that the outcome for him, looked at at the time of trial, would have been materially different had he been treated nine months earlier. Since the burden of proof lies on the claimant that means it should be taken as more probable than not that, treated earlier, the claimant would nonetheless have had at some stage to undergo high dose chemotherapy with stem cell harvesting, would have relapsed, and would thereafter have had a very poor prognosis for survival …" "
"57. The claimant's life expectancy now has not been the subject of direct evidence, though life expectancy is an essential piece of information for the calculation of future loss, both during an expected life period, and for a lost years claim afterwards. I think that if possible a figure must be arrived at. It is not permissible to take the loss to retirement age and discount it for the claimant's own risk of mortality (as opposed to the discount applied for the male population as a whole). The finding I have made is that he has a 25% chance of surviving five years. The present state of his chances was only expressed as to five years. It would be wrong to say from that that his life expectancy is therefore 15 months, because that would be to assume that he will definitely die within five years. In increasing that 15 months without any scientific basis I must be cautious, and err if at all, in the absence of evidence, in favour of the defendant. I would without confidence arrive but nonetheless arrive at an expectation of life from now of four years, and calculations should be based on that. 58. That means that applying the multiplicand I have previously identified to loss of earnings, there will be a four year multiplier appropriately discounted for acceleration and care will continue for the same period. Thereafter, since I have adopted a multiplier / multiplicand approach a lost years' claim is properly sustainable, and I do not regard it as too speculative. The basis is that employment would have continued to normal retirement age at 65, since the assumption on which the claim is predicated is one of disease free survival."
"Classically all that need be shown is that it would probably have made a difference if the defendant had not been in breach of duty. Certainty is not required. The essential thing is to persuade the judge that the harm would probably have been avoided if the defendant had acted properly: it does not matter whether he is easily persuaded, because it is obvious, or is persuaded only with difficulty, because the matter is far from clear. The tendency to state the matter in terms of percentages is to be avoided. 'More likely than not' is a matter of persuasion, not of proof."
"The idea that recovery should be proportional to the cogency of the proof of causation is utterly unacceptable . . . "
"By reason of the Defendant's negligence, the Claimant has suffered pain and injury, loss and damage. PARTICULARS OF PAIN AND INJURY There was rapid spread and development of the Claimant's non-Hodgkin's lymphoma disease at the end of 1995. Had the Claimant been referred in or about November 1994, the malignancy would have been diagnosed and treatment commenced with the disease having progressed no further than stage 1. The treatment would have been by means of either radiotherapy or CHOP chemotherapy. There would have been a very high likelihood of cure. The Claimant would have been unlikely to develop any secondary recurrence, and would not have required the further treatment detailed above. The prospects of obtaining a cure by the time that treatment was in fact commenced were reduced to below 50% . . . PARTICULARS OF LOSS AND DAMAGE The Claimant refers to the provisional schedule of loss and damage served herewith . . . "
" . . . Although he might have suffered them at different times, Mr Gregg would on the balance of probabilities have gone through the same sequence of setbacks and treatments, and his outlook now is not shown to be different from what it would have been had there been no negligence."
"Clearly, if the gist of the complaint were traditionally formulated in terms of contraction of necrosis, the plaintiff would fail to establish the requisite causal link on the balance of probability. The novelty of the case was that the plaintiff attempted to circumvent this result by choosing to formulate the gist of his action, not in terms of the necrosis outcome, but in terms of the lost chance of avoiding that outcome. In other words, although the plaintiff fails to establish causation on the balance of probabilities to one formulation of the damage forming the gist, he seeks to succeed in doing so to an alternative formulation based on loss of a chance. Importantly, the Hotson argument retains the traditional form of the causation test . . ."
" . . . where the claimant is suing in respect of personal injury or property damage, he must persuade the judge that that injury or damage was probably due to the defendant's tort, whereas in cases of financial harm it is enough to show that the claimant had a chance of gain which the defendant has probably caused him to lose. There is nothing irrational in this, unless one supposes it is sensible to speak of 'loss of a chance' without saying what the chance is of. Losing a chance of gain is a loss like the loss of the gain itself, alike in quality, just less in quantity: losing a chance of not losing a leg is not at all the same kind of thing as losing the leg."
Showing the 50 most senior of 89.